| 0 (0%) | 11-11 17:49 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 37.9 | 1-year : | 41.03 |
| Resists | First : | 32.45 | Second : | 35.13 |
| Pivot price | 31.82 |
|||
| Supports | First : | 28.12 | Second : | 23.39 |
| MAs | MA(5) : | 30.94 |
MA(20) : | 31.72 |
| MA(100) : | 31.01 |
MA(250) : | 37.28 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 33.4 |
D(3) : | 33.8 |
| RSI | RSI(14): 50.9 |
|||
| 52-week | High : | 55.33 | Low : | 24.06 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TWST ] has closed above bottom band by 40.1%. Bollinger Bands are 19% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 31.92 - 32.04 | 32.04 - 32.18 |
| Low: | 30.11 - 30.24 | 30.24 - 30.39 |
| Close: | 31.08 - 31.29 | 31.29 - 31.53 |
Mon, 10 Nov 2025
What momentum shifts mean for TWST - July 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Mon, 10 Nov 2025
Will TWST rebound enough to break even - 2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
Mon, 10 Nov 2025
Is TWST showing signs of accumulation - Quarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Mon, 10 Nov 2025
Full technical analysis of TWST stock - Weekly Volume Report & Target Return Focused Picks - newser.com
Sun, 09 Nov 2025
How (TWST) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Thu, 06 Nov 2025
Twist Bioscience (TWST): Exploring Valuation Following Fresh Analyst Coverage and Product Launch Collaboration - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 60 (M) |
| Shares Float | 59 (M) |
| Held by Insiders | 1.7 (%) |
| Held by Institutions | 118.4 (%) |
| Shares Short | 10,860 (K) |
| Shares Short P.Month | 12,820 (K) |
| EPS | -1.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.94 |
| Profit Margin | -23.6 % |
| Operating Margin | -31.4 % |
| Return on Assets (ttm) | -13.9 % |
| Return on Equity (ttm) | -17.6 % |
| Qtrly Rev. Growth | 17.8 % |
| Gross Profit (p.s.) | 2.95 |
| Sales Per Share | 6 |
| EBITDA (p.s.) | -1.98 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -51 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -21.75 |
| PEG Ratio | 0 |
| Price to Book value | 3.93 |
| Price to Sales | 5.21 |
| Price to Cash Flow | -36.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|